Browsing Tag
Peter MacCallum Cancer Centre
2 posts
Nuvalent (NUVL) brings full ALKOVE-1 dataset to ASCO 2026 oral session weeks after neladalkib FDA filing
Nuvalent (NUVL) brings pivotal ALKOVE-1 neladalkib data to ASCO 2026. Here's what the oral session means for its dual NDA strategy and ALK lung cancer treatment.
Semaphore Solutions secures new investment to accelerate Labbit’s AI-driven expansion
Discover how Semaphore Solutions' Labbit is transforming laboratory operations with agentic AI after a new round of funding from Cypress Ridge Capital.